In syngeneic murine models of glioma, melanoma, sarcoma, and colorectal cancer, neoepitope vaccines (delivered with various adjuvants) induced robust antigen-specific IFNγ responses in CD4 and CD8 T cells. Here, IFNG is linked to melanoma.